CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,476
- in 2 filings
Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-16 | Curet Myriam Director | Grant or award · Stock Option | +20,400 | 20,400 | ||
| 2022-09-16 | CHESS ROBERT Director | Grant or award | +10,200 | 233,279 | ||
| 2022-09-16 | CHESS ROBERT Director | Grant or award · Stock Option | +20,400 | 20,400 | ||
| 2022-09-16 | Brainard Diana Director | Grant or award | +10,200 | 28,560 | ||
| 2022-09-16 | Brainard Diana Director | Grant or award · Stock Option | +20,400 | 20,400 | ||
| 2022-09-16 | Ajer Jeffrey Robert Director | Grant or award | +10,200 | 42,710 | ||
| 2022-09-16 | Ajer Jeffrey Robert Director | Grant or award · Stock Option | +20,400 | 20,400 | ||
| 2022-09-13 | EASTHAM KARIN Director | Sale | −21,267 | $3.61 | $77K | 13,033 |
| 2022-08-18 | Zalevsky Jonathan Chief R&D Officer | Sale | −73,716 | $4.65 | $343K | 327,123 |
| 2022-08-16 | Zalevsky Jonathan Chief R&D Officer | Sale | −10,560 | $4.76 | $50K | 400,839 |
| 2022-08-16 | Wilson Mark Andrew SVP & General Counsel | Sale | −3,189 | $4.76 | $15K | 281,188 |
| 2022-08-16 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −2,006 | $4.76 | $10K | 334,859 |
| 2022-08-16 | ROBIN HOWARD W President & CEO | Sale | −13,759 | $4.76 | $65K | 1,017,807 |
| 2022-08-15 | Zalevsky Jonathan Chief R&D Officer | Grant or award | +135,000 | 411,399 | ||
| 2022-08-15 | Zalevsky Jonathan Chief R&D Officer | Grant or award · Common Stock | +270,000 | 270,000 | ||
| 2022-08-15 | Wilson Mark Andrew SVP & General Counsel | Grant or award | +165,938 | 284,377 | ||
| 2022-08-15 | Wilson Mark Andrew SVP & General Counsel | Grant or award · Common Stock | +331,875 | 331,875 | ||
| 2022-08-15 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award | +165,938 | 336,865 | ||
| 2022-08-15 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Common Stock | +331,875 | 331,875 | ||
| 2022-08-15 | ROBIN HOWARD W President & CEO | Grant or award | +410,625 | 1,031,566 |
Page 8 of 18 · 355 trades